Hannah Glaab, PA
Medical · Charleston, SCNPI 1407446149
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 488 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 488 payments — averaging $24.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
- Boston Scientific$1K
- Boehringer Ingelheim$940
- Abbott$842
- E.r. Squibb & Sons, L.L.C.$732
- Johnson & Johnson$685
- plus $6K from 31 others
What the payments were for
- Travel & lodging$6225%
- Food & beverage$11,32795%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 73 | $1,598 |
| Boston Scientific | 15 | $1,317 |
| Boehringer Ingelheim | 48 | $940 |
| Abbott | 13 | $842 |
| E.r. Squibb & Sons, L.L.C. | 35 | $732 |
| Johnson & Johnson | 49 | $685 |
| Novartis | 34 | $646 |
| Pfizer | 29 | $529 |
| Biotronik Inc. | 15 | $528 |
| Amgen | 26 | $465 |
| Esperion Therapeutics, Inc. | 14 | $439 |
| Merck | 21 | $378 |
| Philips North America LLC | 9 | $307 |
| Alnylam Pharmaceuticals Inc. | 16 | $304 |
| Atricure, Inc. | 4 | $278 |
| AstraZeneca | 12 | $266 |
| Novo Nordisk | 10 | $242 |
| Edwards Lifesciences | 3 | $195 |
| Medtronic | 3 | $187 |
| Actelion Pharmaceuticals US, Inc. | 16 | $164 |
| Kiniksa Pharmaceuticals, Ltd. | 8 | $132 |
| Abiomed | 1 | $126 |
| Sanofi-aventis U.S. LLC | 7 | $124 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $96 |
| Scpharmaceuticals Inc. | 3 | $65 |
| Impulse Dynamics (USA) Inc. | 3 | $64 |
| Bridgebio Pharma, Inc. | 2 | $53 |
| Cardiva Medical, Inc. | 2 | $51 |
| Amarin Pharma, Inc. | 3 | $49 |
| United Therapeutics Corporation | 2 | $31 |
| Lexicon Pharmaceuticals, Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Cvrx, Inc. | 1 | $17 |
| Teleflex LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Bayer | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$889
- CARDIOMEMS$264
- AMPLATZER AMULET$260
- WATCHMAN FLX$232
- NEXLIZET$227
- NEXLETOL$227
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$191
- SAPIEN 3 Ultra RESILIA$148
- LINQ II$135
- (5091) Amb Mon & Diag Und$133
- Impella$126
- AMVIA EDGE$124
- JARDIANCE$119
- FARXIGA$108
- Acticor 7 VR-T DX$107
- Rivacor 7 DR-T$107
- Edora 8 DR-T$107
- BioMonitor$107
- LifeVest$101
- CAMZYOS$101
How this compares
$11,963 in reported general payments places this provider in the 95th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 274 | $288,750 |
| EntrestoSacubitril/Valsartan | 67 | $86,457 |
| XareltoRivaroxaban | 57 | $65,552 |
| Repatha SureclickEvolocumab | 41 | $34,403 |
| JardianceEmpagliflozin | 24 | $34,157 |
| Repatha SyringeEvolocumab | 14 | $14,150 |
| NexlizetBempedoic Acid/Ezetimibe | 12 | $12,205 |
| BrilintaTicagrelor | 15 | $6,943 |
| Nebivolol Hcl | 75 | $5,123 |
| Metoprolol Succinate | 257 | $3,644 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 110 | $3,418 |
| Rosuvastatin Calcium | 180 | $2,880 |
| Atorvastatin Calcium | 206 | $2,098 |
| Valsartan | 58 | $1,797 |
| Ezetimibe | 57 | $1,544 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $529 | $288,750274 claims |
| NovartisEntresto | $646 | $86,45767 claims |
| Johnson & JohnsonXarelto | $685 | $65,55257 claims |
| Boehringer IngelheimJardiance | $940 | $34,15724 claims |
| Esperion Therapeutics, Inc.Nexlizet | $439 | $12,20512 claims |
| AstraZenecaBrilinta | $266 | $6,94315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 384 medical providers in South Carolina.
Other medical in Charleston
- Mary MacdonaldCharleston$20K
- Eliza HoughCharleston$13K
- Jennifer HayesCharleston$12K
- Meredith GriffinCharleston$11K
- Lindsey VollonoCharleston$10K
- Brett DalmauCharleston$9K
- Brooke PlewinskiCharleston$8K
- Jessica BrownCharleston$8K
- Heather CheekCharleston$7K
- Anthony PooleCharleston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.